{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:00:23Z","timestamp":1782831623109,"version":"3.54.5"},"reference-count":20,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1297\/cpe.2024-0039","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T18:11:06Z","timestamp":1723486266000},"page":"238-243","source":"Crossref","is-referenced-by-count":3,"title":["Trends in endogenous insulin secretion capacity and anti-islet autoantibody          titers in two childhood-onset slowly progressive insulin-dependent diabetes mellitus          cases"],"prefix":"10.1297","volume":"33","author":[{"given":"Dai","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"},{"name":"Department of Pediatrics, National Hospital Organization Sendai Medical              Center, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Graduate School of Medicine,              Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kawasaki,                E,              Matsuura, N,                Eguchi,            K. Type 1            diabetes in Japan. Diabetologia          2006;49: 828\u201336.","DOI":"10.1007\/s00125-006-0213-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kawasaki,                E, Shimada,                A, Imagawa,                A, Abiru,                N, Awata,                T, Oikawa,                Y, et al.            Committee of type 1 diabetes, Japan Diabetes Society.            Bivalent GAD autoantibody ELISA improves clinical utility and risk            prediction for adult autoimmune diabetes. J Diabetes            Investig          2023;14: 570\u201381.","DOI":"10.1111\/jdi.13980"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Imagawa,              A, Hanafusa,                T,              Miyagawa, J,                Matsuzawa,              Y, Osaka IDDM            Study Group. A novel subtype of type 1 diabetes mellitus            characterized by a rapid onset and an absence of diabetes-related            antibodies. N Engl J Med          2000;342: 301\u20137.","DOI":"10.1056\/NEJM200002033420501"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Kobayashi,                T,              Tamemoto, K,                Nakanishi,              K, Kato,                N, Okubo,                M, Kajio,                H, et al.            Immunogenetic and clinical characterization of slowly progressive            IDDM. Diabetes Care          1993;16: 780\u20138.","DOI":"10.2337\/diacare.16.5.780"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tanaka,              S, Ohmori,                M, Awata,                T, Shimada,                A, Murao,                S,              Maruyama, T,              et al. Diagnostic criteria for slowly            progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): Report by the            Committee on Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus of the            Japan Diabetes Society. Diabetol Int          2015;6: 1\u20137.","DOI":"10.1007\/s13340-014-0199-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shimada,              A, Kawasaki,                E, Abiru,                N, Awata,                T, Oikawa,                Y, Osawa,                H, et al.            New diagnostic criteria (2023) for slowly progressive type 1 diabetes            (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society            (English version). J Diabetes Investig          2024;15: 254\u20137.","DOI":"10.1111\/jdi.14121"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Urakami,              T, Suzuki,                J, Yoshida,                A, Saito,                H,                Mugishima,              H. Incidence of            children with slowly progressive form of type 1 diabetes detected by the urine glucose            screening at schools in the Tokyo Metropolitan Area. Diabetes            Res Clin Pract          2008;80: 473\u20136.","DOI":"10.1016\/j.diabres.2008.01.029"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Urakami,              T, Miyamoto,                Y,                Matsunaga,              H, Owada,                M,              Kitagawa,            T. Serial changes            in the prevalence of islet cell antibodies and islet cell antibody titer in children            with IDDM of abrupt or slow onset. Diabetes Care          1995;18: 1095\u20139.","DOI":"10.2337\/diacare.18.8.1095"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Reinehr,              T, Schober,                E, Wiegand,                S, Thon,                A, Holl,                R, DPV-Wiss            Study Group. Beta-cell autoantibodies in children with type            2 diabetes mellitus: subgroup or misclassification? Arch Dis            Child          2006;91: 473\u20137.","DOI":"10.1136\/adc.2005.088229"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Urakami,              T, Yoshida,                A, Suzuki,                J, Saito,                H, Wada,                M,                Takahashi,              S, et al.            Differences in prevalence of antibodies to GAD and IA-2 and their titers            at diagnosis in children with slowly and rapidly progressive forms of type 1            diabetes. Diabetes Res Clin Pract          2009;83: 89\u201393.","DOI":"10.1016\/j.diabres.2008.09.050"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kawasaki,                E. Anti-islet            autoantibodies in type 1 diabetes. Int J Mol Sci          2023;24: 10012.","DOI":"10.3390\/ijms241210012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kasuga,              A, Maruyama,                T,              Nakamoto, S,                Ozawa, Y,                Suzuki, Y,                Saruta,            T. High-titer            autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin            and IA-2 predicts insulin requirement in adult diabetic patients.            J Autoimmun          1999;12: 131\u20135.","DOI":"10.1006\/jaut.1998.0261"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takino,              H, Yamasaki,                H, Abiru,                N, Sera,                Y, Abe,                T,              Kawasaki, E,              et al. Antibodies to GAD in Japanese            patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a            predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi,            Osaka) study for GAD Ab(+) diabetes. Diabet Med          2002;19: 730\u20134.","DOI":"10.1046\/j.1464-5491.2002.00646.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kawasaki,                E,              Nakamura, K,                Kuriya, G,                Satoh, T,                Kuwahara,            H, Kobayashi,                M, et al.            Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc            transporter 8 improve the prediction of early insulin requirement in adult-onset            autoimmune diabetes. J Clin Endocrinol Metab          2010;95: 707\u201313.","DOI":"10.1210\/jc.2009-1733"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Maruyama,                T, Tanaka,                S, Shimada,                A, Funae,                O, Kasuga,                A,                Kanatsuka,              A, et al.            Insulin intervention in slowly progressive insulin-dependent (type 1)            diabetes mellitus. J Clin Endocrinol Metab          2008;93: 2115\u201321.","DOI":"10.1210\/jc.2007-2267"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Buzzetti,                R, Tuomi,                T,              Mauricio, D,                Pietropaolo,              M, Zhou,                Z,              Pozzilli, P,              et al. Management of latent autoimmune            diabetes in adults: A consensus statement from an international expert            panel. Diabetes          2020;69: 2037\u201347.","DOI":"10.2337\/dbi20-0017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shah,              AS, Zeitler,                PS, Wong,                J, Pena,                AS,              Wicklow, B,                Arslanian,              S, et al.            ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in            children and adolescents. Pediatr Diabetes          2022;23: 872\u2013902.","DOI":"10.1111\/pedi.13409"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oikawa,              Y, Kondo,                T, Shimada,                A, Seino,                Y, Kitaoka,                M. Actual            condition survey regarding mismatch of measurements between radioimmunoassay and            enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in            real-world clinical practice. J Diabetes Investig          2019;10: 685\u20139.","DOI":"10.1111\/jdi.12955"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kawasaki,                E, Okada,                A, Uchida,                A,              Fukuyama, T,                Sagara, Y,                Nakano, Y,              et al. Discrepancy of glutamic acid            decarboxylase\u00a065 autoantibody results between RSR radioimmunoassay and enzyme-linked            immunosorbent assay in patients with type\u00a01 diabetes is related to autoantibody            affinity. J Diabetes Investig          2019;10: 990\u20136.","DOI":"10.1111\/jdi.12996"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kawasaki,                E,              Fukuyama, T,                Uchida, A,                Sagara, Y,                Tamai, H,                Nakano, Y,              et al. Characterization of patients with            diabetes who were incidentally found to be glutamic acid decarboxylase            autoantibody-positive by bridging-type enzyme-linked immunosorbent          assay. J Diabetes Investig          2020;11: 1507\u201310.","DOI":"10.1111\/jdi.13307"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/4\/33_2024-0039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:29:47Z","timestamp":1728088187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/4\/33_2024-0039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2024-0039","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2024-0039"}}